HBM4003

· Harbour BioMed (Guangzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HBM4003, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study [Phase 1]